Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948441 · ClinicalTrials.gov registry record · NA
Pediatric Ethanol Lock Therapy Study.
A NA study of Catheter-Related Infections, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT00948441: Completed NA study of Catheter-Related Infections, sponsored by University of Pittsburgh.
NCT00948441 is a NA study of Catheter-Related Infections that has completed, run by University of Pittsburgh. The registered enrollment target is 16 participants, below the 2,094-participant average among 5 other Catheter-Related Infections trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948441, a NA study of Catheter-Related Infections, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a double-blind crossover design to compare prophylaxis with ethanol lock therapy versus placebo lock therapy (heparin). The primary outcome measure will be the number of catheter related blood stream infections (CRBSI) in each time period.
Primary Outcome
For the purpose of this study, episodes of catheter related blood stream infections were considered as the primary outcome measure. An episode of infection was defined as more than one positive blood culture obtained from the catheter requiring antibiotic therapy. Each episode after enrollment was recorded in its appropriate study period: ethanol lock, placebo lock, or washout period. If a patient had a catheter related blood stream infections, the study locks were held until after the number of
Conditions Studied
Interventions
- DRUG 25% ethanol
- OTHER heparin lock
Study Locations (1)
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT00948441 record still lists
NCT00948441 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 2,094-participant average among 5 other Catheter-Related Infections trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Catheter-Related Infections appearing as the primary indexed condition, and to 2 interventions - of which 25% ethanol is the first listed.
NCT00948441 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00948441 about?
NCT00948441 is a clinical study titled "Pediatric Ethanol Lock Therapy Study.". This study is a double-blind crossover design to compare prophylaxis with ethanol lock therapy versus placebo lock therapy (heparin). The primary outcome measure will be the number of catheter related blood stream infections (CRBSI) in each time period.
What is the current status of trial NCT00948441?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2008-08. Estimated completion is 2014-12.
What conditions does trial NCT00948441 study?
This clinical trial studies the following conditions: Catheter-Related Infections.
What interventions are being tested in trial NCT00948441?
The interventions under investigation include: 25% ethanol (DRUG), heparin lock (OTHER).
Who is sponsoring clinical trial NCT00948441?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00948441 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheter-Related Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Testing a Patient Safety Display in the Hospital Setting
COMPLETED · NA
-
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
COMPLETED · NA
-
Foley Catheter vs a Self-contained Valved Urinary Catheter
COMPLETED · NA
-
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
RECRUITING · Phase 4
-
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia